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The precise time of appearance of the first hematopoi- 
etic stem cell activity in the developing mouse embryo 
is unknown. Recently the aorta-gonad-mesonephros 
region of the developing mouse embryo has been 
shown to possess hematopoietic colony-forming ac- 
tivity (CFU-S) in irradiated recipient mice. To ,deter- 
mine whether the mouse embryo possesses definitive 
hematopoietic stem cell activity in the analogous AGM 
region and to determine the order of appearance of 
stem cells in the yolk sac, AGM region, and liver, we 
transferred these embryonic tissues into adult irradi- 
ated recipients. We report here the long-term, com- 
plete, and functional hematopoietic repopulation of 
primary and serial recipients with AGM-derived cells. 
We observe potent hematopoietic stem cell activity in 
the AGM region before the appearance of yolk sac and 
liver stem cell activity and discuss a model for the mat- 
uration of stem cell activity in mouse embryogenesis. 
Introduction 
Hematopoietic cell development begins in the mouse em- 
bryo at approximately day 7 of gestation and is thought 
to originate in the yolk sac and proceed to the fetal liver 
before becoming resident in the adult bone marrow. The 
first visible differentiated hematopoietic cells in the concep- 
tus are of the erythroid lineage. They appear in the 7.5 day 
post coitum (dpc) yolk sac (Russell and Bernstein, 1966; 
Russell, 1979) and later at 9 dpc, in the fetal liver (Johnson 
and Jones, 1973; Houssaint, 1981). Committed multilineage 
progenitors, colony-forming unit-culture (CFU-C), for ery- 
throid and myeloid lineages have been reported in in vitro 
cultures of yolk sac as early as 7-8 dpc (Moore and Met- 
calf, 1970; Johnson and Barker, 1985; Wong et al. 1986). 
Fetal liver was also found to produce committed myeloid 
precursors at 9 dpc and onwards (Moore and Metcalf, 
1970; Samoylina et al., 1992). In multilineage (erythroid- 
myeloid) in vivo progenitor assays, colony-forming unit- 
spleen (CFU-S) activity has been reported in 8 dpc yolk sac 
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(Moore and Metcalf, 1970), although many investigators 
have been unable to detect such activity until 9 dpc (Perah 
and Feldman, 1977; Symann et al., 1978; Samoylina et 
al., 1990; Medvinsky, 1993). Recently, the aorta-gonad- 
mesonephros (AGM) region of the embryo has been dem- 
onstrated to be a novel site of hematopoiesis in the mouse 
embryo and to contain CFU-S (erythroid-myeloid) progen- 
itors beginning at 9 dpc (Medvinsky et al., 1993). Progeni- 
tor activities in the AGM, yolk sac, and fetal liver were 
compared for the production of in vivo macroscopic colo- 
nies on the spleen at 8 days (CFU-&) and 11 days (CFU- 
S,,) posttransplantation. The first statistically significant 
CFU-Ss progenitors appear at the 24 somite pair stage 
concurrently in the embryo body and the yolk sac. Both 
the number and frequency of CFU-S progenitors in the 
AGM region surpasses that of yolk sac and peaks in the 
38-40 somite pair stage of the 10 dpc embryo. This activity 
reaches a maximum in the AGM region just before the 
activity can be found in the fetal liver, suggesting that the 
AGM region may be the source of liver multilineage pro- 
genitors. However, these assays are specific only for the 
myeloid and erythroid lineages, not the lymphoid lineages. 
Progenitors for T lymphoid lineage cells have been found 
in the embryonic yolk sac beginning at 8-9 dpc using in 
vitro thymic organ cultures (Liu and Auerbach, 1991) or 
stromal cell cocultures (Palacios and Imhof, 1993). In vitro 
cocultures of yolk sac (Cumano et al., 1993; Palacios and 
Imhof, 1993; Huang et al., 1994), embryo body (Ogawa 
et al., 1988; Huang and Auerbach, 1993), and the splanch- 
nopleuric mesoderm (Godin et al., 1993) with stromal cell 
lines that support the differentiation of B lymphoid cells 
have demonstrated B cell activity beginning as early as 
8-9 dpc in these tissues. Thus, all hematopoietic lineages 
can be produced by early embryonic tissues. However, 
a common embryonic progenitor-stem cell for all these 
lineages cannot be examined using these assays. 
The most stringent and reliable measure of pluripotential 
hematopoietic stem cell (HSC) activity has been through 
the generation of adult radiation chimeras. Complete and 
long-term hematopoietic repopulation of adult mice has 
previously been demonstrated for whole (Micklem et al., 
1966) and stem cell-enriched (Spangrude et al., 1988) 
adult bone marrow and fetal liver (Jordan et al., 1990). 
In addition, pluripotential and long-term HSC activity has 
been observed from late 11 dpc yolk sac, long term after 
transplantation into lethally irradiated mouse recipients 
(Moore and Metcalf, 1970; Huang and Auerbach, 1993). 
The reports of HSC activity in yolk sac at earlier times in 
mouse embryonic development are sparse either because 
the procedures used for the identification of such cells in 
vivo are technically difficult or because such activity is 
limited. While two groups failed to find HSC activity in 9 dpc 
yolk sac (Sonoda et al, 1983; Harrison et al., 1979), two 
other groups have shown that such yolk sac activity prior 
to 11 dpc can lead to the long-term high level repopulation 
of only the erythroid lineage (Toles et al., 1989) or low 
level lymphoid-restricted repopulation (Weissman et al., 
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1977, 1978). These cells were delivered transplacentally 
or to the yolk sac of the embryo. Thus, the onset and 
temporal expansion of pluripotential HSC activity (equiva- 
lent to the stem cell activity found in the adult bone marrow) 
in the early developing mouse embryo, particularly in the 
AGM region, is unknown and in the yolk sac is uncertain. 
In birds, adult hematopoietic cells are derived from intra- 
body stem cells (Dieterlen-Lievre, 1975; Dieterlen-Lievre 
and Martin, 1981), which are thought to reside in the meso- 
dermal region containing the dorsal aorta (Cormier and 
Dieterlen-Lievre, 1988). As shown in elegant grafting ex- 
periments between quail embryos and chick yolk sacs, 
intraembryonic cells but not those of the yolk sac contrib- 
ute to the complete adult avian blood system. The amphib- 
ian system has an analogous intraembryonic site, which 
contributes adult hematopoietic stem cell activity (Turpen 
et al., 1981; Maeno et al., 1985). Since the analogous site 
in the developing mouse embryo has not been examined 
for adult repopulating HSC activity, we performed direct 
transplantation of mouse AGM cells into lethally irradiated 
mouse recipients to test for complete long-term repopulat- 
ing potential. We report here the results of radiation chime- 
ras produced with embryonic tissues of 8-l 1 dpc mouse 
embryos. We demonstrate the complete, multilineage, 
long-term repopulation of such mice with cells of the AGM 
region and observe potent HSC activity in this intraembry- 
onic region prior to the detection of stem cell activity in 
the yolk sac and the fetal liver. These in vivo results, in 
combination with previous in vitro progenitor and CFU-S 
data, suggest a novel model for mammalian HSC matu- 
ration. 
The AGM Region of Developing Mouse Embryo 
Contains Long-Term Repopulating 
Hematopoietic Cell Activity 
One criterion for the assessment of hematopoietic stem 
cell activity is the long-term engraftment of the blood sys- 
tem of recipient mice. It has been shown that clonal stabili- 
zation of stem cell-derived hematopoietic repopulation oc- 
curs only 4-6 months posttransplantation (Jordan and 
Lemischka, 1990). The ability of embryonic tissues, partic- 
ularly AGM region cells, to contribute to the prolonged 
hematopoietic repopulation of lethally irradiated adults 
was tested using cells from genetically marked embryos. 
A P-globin transgene and the Y chromosome sequences 
Y-2 and Sry were used in these studies as markers for 
donor embryonic cells. As shown in Figure 1, embryos 
could be generated such that the donor genetic markers 
would be present only in contributing embryonic cells and 
not in maternal blood cells (a potential source of contami- 
nating engrafting cells). Heterozygous or homozygous 
males transgenic for the human p-globin locus were mated 
with nontransgenic females. Embryo body or AGM region 
cells, as well as yolk sac, liver, circulating, and body rem- 
nant cells were prepared from a pooled mixture of male/ 
female, transgenic/nontransgenic embryos at 8, 9, 10, or 
11 dpc and intravenously injected as a single cell suspen- 
sion into lethally irradiated female recipients. Tissues from 
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Figure 1. Strategy for the Generation of Genetically Marked Embryos 
and Injection of Embryonic Tissues into Recipients 
To avoid contamination of embryonic tissues by maternal blood- 
derived hematopoietic progenitor cells, males heterozygous or homo- 
zygous for the human P-globin locus (Strouboulis et al., 1992) were 
used to produce genetically marked embryos. The embryonic tissues 
were dissected as described by Medvinsky et al. (1993), pooled, and 
collagenase-treated, and intravenously injected into lethally irradiated 
female recipient mice. 
the individual embryos included in each experimental pool 
were typed (by polymerase chain reaction [PCR] or South- 
ern blot) for the presence of the transgene or Y chromo- 
some marker so as to determine the percentage of marked 
cells injected. A limiting dose of unmarked syngeneic fe- 
male bone marrow cells (Harrison, 1980) was also injected 
to aid the recipients in short-term survival following irradia- 
tion. Short-term and long-term repopulation analyses were 
performed on recipient peripheral blood DNA by PCR for 
the presence of the SW male-specific gene. 
As shown in Figure 2A, blood DNA samples from ani- 
mals receiving the various embryonic tissues were nega- 
tive (<0.10/o) for donor Sry signal when derived from 8 or 
9 dpc embryos. Only when 10 dpc tissues (Figure 28) or 
11 dpc tissues (Figure 2C) were transplanted did recipients 
yield Sry-positive signal. Three animals receiving 10 dpc 
AGM cells were S/y positive, while those receiving body 
remnant, circulating, or liver cells were negative. The 10 
dpc AGM recipients were repopulated to varying degrees 
(<O.l% to >lO%) at 1 month posttransplantation. At 
3 months postinjection, engraftment persisted only in the 
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Figure 2. Temporal Analysis of Recipient Pe- 
ripheral Blood after Injection of 8 dpc through 
11 dpc Embryonic Cells 
Female recipients were injected with (A) 8 or 
9 dpc, (B)lO dpc, and (C) 11 dpc embryonic 
tissues generated from matings of heterozy 
gous male f3-globin transgenic mice. Periph- 
eral blood was examined by PCR analysis at 
3 months (for 8 dpc recipients), 3.5 months (for 
9 dpc recipients), 1 month (for 10 dpc recipi- 
ents), and 3 months (for 11 dpc recipients) post- 
transplantation. The embryonic tissues trans- 
planted were the following: (E), whole embryo; 
(Y), yolk sac; (C), embryonic circulating cells; 
(L), fetal liver; (A), AGM; (R), body remnants; 
and (B), control adult bone marrow. Autoradio- 
grams of Southern blots after gel electrophore- 
sis are shown. Filters were hybridized with Sly 
and myogenin (for DNA normalization) probes 
B 
and the contribution standards were derived 
by diluting male into female genomic DNA. The 
two ~1% positive 10 dpc AGM recipients lost 
their male Sly signal by 3 months posttrans- 
plantation. The third animal (>lO% repopu- 
lated) is animal 9.2 shown in Figure 3A and 
is the predecessor of secondary and tertiary 
animals shown in Figure 6. All hone marrow 
control recipients were completely repopu- 
lated. 
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Recipient 9.2 (A) was sacrificed and analyzed 
at 7.5 months postinjection of one embryo 
equivalent (1.8 x 1Oq AGM cells. Of the em- 
bryos used in this experiment, 50% were male 
as determined by Sry PCR. However, none of 
the embryos were positive for the globin 
transgene. Recipient 8.2 (B) was sacrificed 
and analyzed at 8 months postinjection of one 
embryo equivalent (3.7 x lo4 cells) of AGM 
cells. Of the embryos used, 50% were male as 
determined by Sry PCR and all embryos were 
globin transgenic since a homozygous male 
was used for the mating. Recipient mouse 
DNAs were isolated from the following tissues: 
(L), lymph nodes; (Th), thymus; (S), spleen; (B), 
bone marrow; (Bl), peripheral blood; (T), 
splenic T cells; (B), splenic B cells; (S), splenic 
macrophages; (P) peritoneal macrophages; (B), 
bone marrow macrophages; and (M), bone 
marrow mast cells, cut with EcoRI, blotted as 
previously described (Strouboulis et al., 1992), 
and hybridized with the human globin and 
Thy-7 probes and rehybridized with a Y-2 
probe. Contribution controls indicate 1, 0.5, 
0.2, 0.1, and 0 copies of the globin transgene 
(12 kb hybridizing band) or copy equivalents 
of the Y-2 repetitive gene (2.1, 1.9, and 1.5 kb 
hybridizing bands). The endogenous Thy-7 
gene (8.2 kb hybridizing band) was used as 
a DNA normalization control. Quantitation of 
donor-derived repopulation was determined by 
densitometry and phosphorimaging and per- 
centage of engraftment values are indicated 
under each lane. The value for peripheral blood repopulation (*) could not be determined accurately, since degradation of high molecular weight 
DNA took place during preparation of the sample. Tissue DNA samples from a transplanted adult bone marrow recipient are also shown. This 
female recipient was transplanted at the same time as the 9.2 mouse, received 4 x IO6 male adult bone marrow cells, and was fully engrafted. 
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Table 1. Frequencies of Long-Term Repopulating Activity in the Embryo 
Embryo 
age 
Donor embryonic 
tissues 
Number of positive recipients 
Number of recipients 
Embryo equivalents 
per recipient 
Frequency of 
repopulation 
Day 10 112 AGM 3/96 1.16 
121 yolk sac o/74 1.63 
66 liver 0143 1.53 
33 circulation 0127 1.22 
Day 11 16 AGM 11119 0.95 
14 yolk sac 10117 0.82 
10 liver 6115 0.67 
13 circulation 019 1.45 
3% 
00/O 
0% 
0% 
73% 
59% 
40% 
0% 
Embryonic tissues from 10 and 11 dpc were dissected and AGM, yolk sac, liver, and circulating cells were isolated. The number of donor embryonic 
tissues transplanted, the number of positive recipients out of the number of surviving transplant recipients, the average number of embryo equivalents 
per recipient, and the frequency of repopulation are indicated. Transplantation recipients were examined by Sry or human globin-specific PCR 
for the presence of donor male or transgenic cells in peripheral blood DNA at greater than 6 months postinjection. Each animal was independently 
analyzed at least two times and only animals with signal representing greater than 10% repopulation by donor cells are considered positive, 
Fourteen individual transplantation experiments were performed using IO dpc embryonic tissues and four individual transplantation experiments 
were performed using 11 dpc tissues. Embryos were pooled before injection of single cell suspensions into female recipients. The number of cells 
in one embryo equivalent of AGM was 1.4-5 x 104, yolk sac was 3-9.2 x 104, liver was 0.9-6.7 x 104, and the circulation was 1-18 x 104. In 
four experiments with 10 dpc tissues, one embryo equivalent was injected per recipient and in eight experiments, the embryo equivalents injected 
ranged from 9-0.03 per recipient. In two experiments with 11 dpc tissues, one embryo equivalent was injected per recipient and in two experiments, 
the embryo equivalents injected ranged from 3-0.03 per recipient. A limiting number of normal, sygeneic female bone marrow (2 x IOq or spleen 
(2.5 x 103 cells were coinjected to promote short-term survival of recipients. Only 50% of injected control animals survived, while all irradiation 
controls (no cells injected) died within 14 days. Each experiment also contained adult (male) bone marrow control recipients, which always tested 
positive for long-term complete engraftment. 
The three positive recipients resulting from the injection of 10 dpc AGM cells were derived from embryonic cells of the 39-41, 34-37. and 34- 
35 somite pair stage and were further examined as shown in Figures 3 and 4. The 11 dpc embryonic tissues were obtained from embryos with 
>42 somite pairs. 
high signal animal yielding>1 0% donor repopulation (data 
not shown). Since this PCR assay was linear only to the 
10% level, Southern blot analysis of the highly engrafted 
10 dpc AGM recipient demonstrated 100% repopulation 
(Figure 3A). Also, the low level signal (<O.l%) found in 
the 10 dpc embryonic circulation transplanted animal was 
absent in this recipient when it was retested at 3 months 
posttransplantation. Thus, 10 dpc AGM cells appear to be 
the most potent embryonic hematopoietic reconstituting 
cells when compared with other transplanted 10 dpc em- 
bryonic cells. Interestingly, at 11 dpc when other investiga- 
tors have found high level repopulating activity in the yolk 
sac, we have found high level (>lO%) repopulation of re- 
cipients receiving 11 dpc AGM, body remnant, or liver 
cells (Figure 2C). Thus, long-term repopulating activity is 
present in most embryonic tissues at 11 dpc. 
The Frequency of Long-Term Repopulating 
Hematopoietic Cell Activity in Developing 
Embryonic Tissues 
To establish more firmly the onset of AGM long-term hema- 
topoietic repopulating activity compared with other embry- 
onic tissues (particularly the yolk sac) and to examine fur- 
ther the frequencies of engraftment by the different 
embryonic tissues, we performed additional transplanta- 
tion experiments. As shown in Table 1 at greater than 
4 months posttransplantation of 10 dpc tissues, 3 highly 
positive (>lO% donor repopulated) recipients were ob- 
tained from the transplantation of 112 AGM regions into 
96 recipients (- 1 .16 embryo equivalents per recipient). In 
contrast, when 121 yolk sacs or 66 livers were transplanted 
into 74 or 43 recipients (average of 1.63 and 1.53 embryo 
equivalents each), respectively, no mice were positive for 
the donor marker. Short term after transplantation we ob- 
served numerous low level donor positive recipients. 
Seven recipients receiving AGM cells and three recipients 
receiving yolk sac cells were found to be low level repopu- 
lated (between 1% and 5%) at 2 months but lost all donor- 
derived cells when examined later. Only the three 10 dpc 
AGM recipients originally testing >10% donor positive re- 
mained positive long term after transplantation. These ex- 
periments suggest that the AGM region acquires detect- 
able long-term high level repopulating activity at 10 dpc 
(between the 34 and 41 somite pair stage) before yolk sac 
and liver and is limiting since only 3% of the recipients 
are high level engrafted. 
When 11 dpc AGM cells were transplanted (- 0.95 em- 
bryo equivalents per recipient), repopulation of recipients 
was found at a much higher frequency (73%) than with 
10 dpc AGM cells. In addition, 11 dpc yolk sac and liver 
cells were found to engraft long-term (33 months) recipi- 
ents to high levels (>lO%) and at high frequencies: 59% 
and 40%, respectively (average of 0.82 and 0.67 embryo 
equivalents per recipient). No long-term repopulation was 
observed in recipients of 10 or 11 dpc embryonic circulat- 
ing cells. Thus, we have confirmed the high level repopu- 
lating frequency of day 11 pc yolk sac cells seen by other 
investigators (Moore and Metcalf, 1970; Huang and Auer- 
bath, 1993) and demonstrated that yolk sac is not the only 
day 11 embryonic tissue with high frequency stem cell 
activity; AGM region and liver are also highly active at this 
time in embryonic development. 
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Figure 4. Multilineage Marker Analysis of the 
Long-Term Engrafted 1.2 Mouse Injected with 
a Mixture of 10 dpc Embryonic Cells 
Recipient 1.2 was sacrificed and analyzed at 
7 months postinjection of one embryo equiva- 
lent of a mix of AGM (1.2 x 103 cells from the 
34-35 sp stage, liver (0.96 x IV) cells from 
the 32-35 sp stage, and yolk sac (5 x 1 Oq cells 
from the 34-35 sp stage. Of the AGM cells used 
(total of 6 pooled embryos), 50% ‘were derived 
from male embryos and 50% were globin 
transgene line 72 positive embryos. Of the liver 
cells used (total of 5 pooled embryos), 40% 
werederivedfrom maleembryosand20%from 
globin transgene line 2 positive embryos. Of 
the yolk sac cells (total of 12 pooled embryos), 
75% were derived from male embryos and 
56% from globin transgene line 15 positive em- 
bryos. DNAs were isolated from hematopoietic 
tissues and enriched lineages, analyzed as de- 
scribed in Figure 3, and hybridized with human 
40 <3 42<353 3672100 c3 0 globin and Thy-7 probes (A) and then reprobed 
with a Y-2 fragment (6). Control lanes in (A) 
demonstrate transgenic line-specific EcoRl integration fragments: lane 1, nontransgenic DNA; lane 2, DNA from a line 72 transgenic mouse; lane 
3, DNA from a line 2 transgenic mouse; and lane 4, DNA from a line 15 transgenic mouse. Contribution controls indicate 1, 0.5, 0.2, 0.1, and 0 
copies of the globin transgene or copy equivalents of the Y-2 repetitive gene. Quantitation of donor globin and Y-2 signal were performed by 
phosphorimaging and densitometry with the Thy-7 hybridization as a normalization control. The Thy-7 signal in the contribution controls varies 
due to the total amount of DNA per lane: lane 1, 10 pg male DNA; lane 2, 5 pg male DNA; lane 3, 1 pg male DNA; and lane 4, 0.5 pg female 
DNA. Percentage donor engraftment is indicated under each lane. Tissue DNA samples from an adult bone marrow recipient control are also 
shown in (B). This female recipient was transplanted at the same time as the 1.2 mouse, received 4 x IO6 male adult bone marrow cells, and 
was fully &grafted. 
Repopulation of AGM Recipient and complete repopulation of a lethally irradiated adult 
Mice Is Multilineage recipient. 
A definitive characteristic of hematopoietic stem cell activ- 
ity is the repopulation of all the mature blood lineages of 
the recipient. After the initial peripheral blood DNA PCR 
screening, weexamined theextent of multilineage repopu- 
lation in the three positive primary recipients that received 
10 dpc AGM cells. Hematopoietic tissues (blood, thymus, 
spleen, and bone marrow) and specific cell lineages 
(B and T cells, macrophages, and mast cells) were as- 
sayed by Southern blot analysis for the presence of the Y 
chromosomal and the 8-globin transgene markers. When 
males heterozygous for the transgene are used for the 
generation of donor embryos (see Figure l), the two inde- 
pendently segregating markers (Y chromosome and glo- 
bin transgene) should be individual in 25% and overlap- 
ping in 25% of the injected donor cells (total of 75% of 
donor cells are genetically marked). 
Long-term engraftment of mouse 9.2 is shown in Figure 
3A. This recipient, which received one embryo equivalent 
of AGM cells (1.8 x 103 from a pooled mixture of three 
male and three female embryos (all were nontransgenic 
and of the 39-41 somite pair stage) is highly repopulated 
in all the hematopoietic tissues and lymphoid and myeloid 
lineages at 7.5 months postinjection. The marked donor- 
derived repopulating cells are male nontransgenic cells 
as determined by hybridization with Y chromosome (y-2) 
and globin transgene-specific probes. Percentage of en- 
graftment in each tissue and lineage varied and ranged 
from 40%-100% donor-derived cells as internally quanti- 
tated against Thy-l endogenous gene hybridization. Thus, 
one embryo equivalent of AGM cells are capable of full 
The B.2 recipient mouse shown in Figure 38 demon- 
strates reconstitution with one embryo equivalent of AGM 
cells (3.7 x 1 O4 cells) from a mixture of eight 34-37 somite 
pair embryos (four male, four female; eight transgenic). 
This animal is very highly engrafted in all hematopoietic 
tissues and lineages (macrophages and Band T lymphoid 
cells) at 8 months posttransplantation. Levels of en- 
graftment ranged from 63%-100% in the hematopoietic 
tissues and 70%-92% in the enriched cultured lymphoid 
and myeloid lineages. These cells are derived from female 
transgenic-marked HSCs as determined by hybridization 
to the globin transgene probe (normalized by endogenous 
Thy-7 signal) and lack of signal with the y-2 probe. The 
combined results of mouse 9.2 and 8.2 demonstrate that 
neither genetic marker, Y chromosome, nor globin trans- 
gene has an effect on the long-term multilineage engraft- 
ment of these recipients and suggest that one or very few 
AGM cells is capable of full and complete reconstitution. 
A third positive recipient mouse, I.2 is shown in Figure 
4. This recipient received a mixture of embryonic cells (32- 
35 somite pairs) to examine the competitive hematopoietic 
repopulation potential of AGM cells as compared with liver 
and yolk sac cells. The injected mixture of cells was de- 
rived from three separate globin transgenic lines with dif- 
fering transgene chromosomal integration sites: AGM 
cells from line 72, yolk sac cells from line 15, and liver 
cells from line 2. Thus, the origin of the repopulating cells 
in the recipient could be determined by EcoRl Southern 
blot analysis (Figure 4A, controls) for the unique frag- 
ments: a 12 kb fragment for line 72, 5.3 and 4.8 kb frag- 
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ments for line 15, and a 3.5 kb fragment for line 2. High 
level engraftment (36%-l 00%) is observed in most hema- 
topoietic tissues and lineages as determined by globin 
transgene (Figure 4A) and Y-2 probe (Figure 48) hybridiza- 
tions. Three main patterns emerge from these blots. The 
first and predominating pattern shows equivalent signals 
for both the globin transgene and Y-2 markers in lymph 
node, spleen, blood, and splenic B and T cells. The hy- 
bridizing globin fragment migrates at 12 kb (line 72), indi- 
cating repopulation by AGM-derived cells. Thus, most he- 
matopoietic cells are derived from male AGM cells. The 
second pattern is observed in a single lineage, the splenic 
macrophages of this recipient. These cells are male de- 
rived (Y-2 positive) but do not carry the line 72 globin 
transgene marker. Instead, a globin hybridizing fragment 
migrating at 3.5 kb indicates splenic macrophage produc- 
tion from line 2, fetal liver cells. This marker is probably 
beneath the limits of detection in whole spleen DNA and 
suggests the presence of a low frequency long-term single 
lineage repopulating cell in 10 dpc liver. The liver at this 
early stage of development has been found to be capable 
of producing macrophages on adult bone marrow stroma 
in Dexter-type cultures (A. M. and N. L. Samoylina, unpub- 
lished data). Finally, the third pattern is found in the bone 
marrow, thymus, and peritoneal and bone marrow macro- 
phages. While no or faint globin (line 72) and Y-2 hybridiz- 
ing signals are seen, it appears that most of these cells 
are derived from female nontransgenic cells and could 
be donor or endogenous in origin. Thus, this recipient is 
repopulated by at least three stem/progenitor cells. These 
results strongly suggest that in 10 dpc hematopoietic tis- 
sues, the most competent cells for long-term high level 
multilineage hematopoietic engraftment under our strin- 
gent transplantation conditions are from the AGM region. 
In addition, we have performed multilineage analysis on 
long-term donor-repopulated recipients receiving 11 dpc 
AGM region, yolk sac, or liver cells. All three embryonic 
tissues were capable of high level repopulation of all hema- 
topoietic tissues and lineages analyzed (data not shown). 
Functional Repopulation of the Erythroid Lineage 
in Long-Term Repopulated AGM Recipients 
While we have shown that AGM cells are capable of pro- 
ducing myeloid and lymphoid lineage cells in vivo, we 
sought to determine whether erythroid lineage cells are 
also produced. It was also of interest to determine whether 
AGM stem cell-derived erythroid cells would be capable 
of appropriate developmental expression of globin genes. 
The use of the complete human globin transgene locus 
allowed us to detect the presence of functional donor- 
derived human globin in etythrocytes by Sl RNA analysis 
and to determine whether embryonic, fetal, and/or adult glo- 
bins were being produced in the peripheral blood of AGM 
recipient mice (Figure 5). When tested at 6 months post- 
transplantation, the peripheral blood of one out of two ani- 
mals receiving 10 dpc AGM cells was found to be highly 
positive for adult human P-globin expression (Figure 5, 
lanes 4 and 5). No human E or y-globin expression was 
observed. The positive 10 dpc AGM recipient was the 8.2 
mouse, described in Figure 3B. When quantitative expres- 
hu& 
- 
- 
- 
1234567 
66 0 58 100 
Figure 5. Expression of the Human E, y, and 6 Transgenes in the 
Peripheral Blood of AGM Transplantion Recipients by Sl Nuclease 
Protection Analysis 
Si nuclease protection was performed with probes specific for human 
y-, B-, and E-glObin transgene RNAs and endogenous mouse B major 
globin RNA (erythroid lineage control). Protected fragments are indi- 
cated at left. RNA samples protected in each lane are as follows: lane 
1, 10 dpc line 72 transgenic yolk sac RNA (38 somite pairs); lane 2, 
12 dpc line 72 transgenic fetal liver RNA; lane 3, line 72 transgenic 
adult spleen RNA; lanes 4 and 5, peripheral blood RNA from two 
animals injected with line 72 transgenic (34-37 somite pair) 10 dpc 
AGM cells at 8 months posttransplantation; lane 6, peripheral blood 
RNA from an animal injected with (44 somite pair) 11 dpc AGM cells at 
approximately 2 months posttransplantation; lane 7, peripheral blood 
RNA from an animal injected with human globin transgenic adult bone 
marrow at approximately 2 months posttransplantation. Quantitation 
of expression levels of human fi-globin transgene (indicated beneath 
each sample lane) were performed by densitometry using mouse B 
major expression as an internal control. Since the expression of this 
transgene is known to be copy number-dependent (Strouboulis et al., 
1992), 100% expression indicates the level of a single copy of the 
human 6-globin transgene compared with the diploid level expression 
of the endogenous mouse 6 major gene. The peripheral blood RNA 
sample in lane 4 is from the 8.2 recipient shown in Figure 38. 
sion of the human P-globin transgene of the peripheral 
blood of the 8.2 mouse was compared with that of a fully 
engrafted bone marrow control recipient (100% expres- 
sion), human P-globin RNA was produced to the 66% level 
(66% of the 8.2 blood cells produce RNA to the level ex- 
pected of this single copy transgene; see Strouboulis et 
al., 1992). This level is consistent with the percentage of 
engraftment (63%) determined by DNA analysis of 8.2 
peripheral blood(Figure 38). In addition, arecipient receiv- 
ing 11 dpc AGM cells was found to express human P-globin 
at 2 months postinjection (Figure 5, lane 6). In this recipi- 
ent, as well as numerous other recipients, the level of hu- 
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Figure 6. Analysis of Secondary and Tertiary 
Transplantation Recipients Receiving AGM- 
Derived Hematopoietic Stem Cells 
At 7.5 months posttransplantatian of 10 dpc 
AGM cells, animal 9.2 was sacrificed and 3 x 
IO6 bone marrow cells were injected into two 
lethally irradiated secondary recipients, 9.2A 
and 9.26. At 4 months posttransplantation, the 
secondary recipients were sacrificed and (A) 
numerous hematopoietic tissues and lineages 
were examined by Southern blot analysis for 
the presence of the Y chromosome marker. Ab- 
breviations for the tissues and methods are the 
same as in Figure 3. Contribution controls indi- 
cate copy equivalents of the y-2 repetitive 
gene. Endogenous Thy-7 gene hybridization 
was used as a normalization standard. Quanti- 
tation was performed by phosphorimaging and 
densitometry and percentage donor en- 
graftment indicated under each lane. No pe- 
ripheral blood DNA (minus) was obtained for recipient 9.2A and the percentage engraftment of bone marrow macrophages in both secondary 
recipients was low due to fibroblast overgrowth in the culture. 
(6) PCR analysis of peripheral blood DNA from tertiary recipients 7 weeks after injection of 3 x 108 bone marrow cells from secondary transplant 
mice 9.2A and 9.28. Contribution controls indicate lOO%, IO%, I%, and 0% Sry signal, with myogenin as the normalization standard. The lane 
marked male BM and no cells indicates peripheral blood DNA obtained from recipients at 7 weeks posttransplantation of 4 x 1u6 male bone 
marrow cells or 2.5 x lo5 female spleen cells, respectively. Quantitation was performed by densitometry and percentage engraftment indicated 
under sample lanes. 
man 6-globin expression in peripheral blood was found to 
correspond to the level of engraftment when DNA analysis 
was performed (data not shown). Thus, repopulation in 
the erythroid lineage with genetically marked cells, in addi- 
tion to the repopulation shown in the myeloid and lymphoid 
lineages, indicates the presence of multilineage repopu- 
lating cells in the AGM region of the embryo. 
Serial Transplantation of AGM-Derived Cells 
Results in Long-Term Multilineage Repopulation 
The most stringent test for the presence of long-term self- 
renewing stem cell activity in the AGM region is the serial 
transplantation of bone marrow from the primary recipi- 
ents into secondary recipients for long-term multilineage 
repopulation. Such transplantation was performed at 
8 months postengraftment of mouse 9.2 (Figure 3A). Ini- 
tially, the CFU-S 11 activity of the donor cells was mea- 
sured and resulted in all colonies positive for the y-2 se- 
quence (data not shown). Long-term repopulation of 
secondary recipients was also tested by transplantation 
of bone marrow cells (3 x 10”) from primary recipient 9.2 
into lethally irradiated adult recipients. As shown in Figure 
6A, all hematopoietic tissues and lineages of two second- 
ary recipients, 9.2A and 9.28, were repopulated with donor 
marked cells at 4 months posttransplantation. Hematopoi- 
etic tissue and lineage engraftment of animal 9.2A ranged 
from 12%-86%, while that of animal 9.28 ranged from 
44%-l 00%. When bone marrow cells (3 x 10’) from sec- 
ondary animals 9.2A and 9.28 were transplanted into ter- 
tiary recipients (Figure 6B), again repopulation was ob- 
served. The 9.28 bone marrow contributed to 47% 
repopulation of peripheral blood-nucleated cells and 9.2A 
bone marrow contributed to 3% repopulation at 7 weeks 
posttranplantation as determined by Sry-specific PCR. 
These data indicate that AGM-derived hematopoietic cell 
activity can be serially transplanted and that the level of 
engraftment of the long-term secondary recipients corre- 
sponds well to the percentage of donor-derived cells in 
the bone marrow of the primary recipient (see Figure 3A). 
Discussion 
While previous investigations have lead to the general ac- 
ceptance that the yolk sac functions as the primary and 
only site of hematopoiesis in the early (11 dpc) developing 
mouse embyo (Moore and Metcalf, 1970; Tavassoli, 1994; 
Huang et al., 1994), we have found the presence of potent 
and high frequency HSC activity in the AGM region, as 
well as the liver and the yolk sac. We have shown that 
the AGM-derived hematopoietic cells bear all the hallmark 
characteristics of adult bone marrow HSCs: long-term per- 
sistent engraftment, high level repopulation of all hemato- 
poietic lineages, and the ability to repopulate secondary 
and tertiary recipients serially. In the 11 dpc AGM region, 
this HSC activity appears at a higher frequency than in 
liver or yolk sac. Earlier in development, at 10 dpc, we 
observed HSC activity only in the AGM region. Since only 
3% of AGM recipients were engrafted, long-term high level 
repopulation was limiting, probably reflecting repopulation 
by as few as one HSC. Although we cannot exclude the 
possibility that HSCs exist at a low frequency in 10 dpc 
yolk sac and liver, these data favor the AGM region as 
the initial source of long-term repopulating cells and sug- 
gest that AGM HSCs may migrate to the fetal liver as well 
as the yolk sac by 11 dpc (Medvinsky, 1993). Alternatively, 
AGM HSCs may not be produced in situ, but this region 
may give competence to, maintain, or expand stem cells 
migrating from other sites such as the yolk sac. Interest- 
ingly, the AGM region is a site of stem cell factor and the 
c-kit receptor expression at 10 dpc (Matsui et al., 1990; 
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Figure 7. Proposed Waves of Hematopoietic Activity Entering the Fe- 
tal Liver during Embryonic Development 
Representation of the putative sources of origin and temporal emer- 
gence of various measureable hematopoietic activities in the liver rudi- 
ment. Waves of hematopoietic activity in the yolk sac and the AGM 
region always precede the onset of committed precursor, CFU-S, and 
repopulating activities in the liver and predict a role for these embryonic 
tissues in establishment of fetal liver hematopoiesis. 
Keshet et al., 1991). This ligand and receptor are known 
to play a role in primordial germ cell expansion (Godin et 
al., 1991; Dolci et al., 1991) hematopoiesis (Russell, 
1979) and CFU-S production (Witte, 1990). 
Surprisingly, we found that HSC activity in the embryo 
develops at a relatively late time in gestation (10 dpc) as 
compared with the appearance of the first differentiated 
hematopoietic cells in the embryonic yolk sac at 7.5 dpc, 
the first CFU-C progenitors at 8 dpc, and the first CFU-S 
progenitors at 9 dpc. Although slightly later in develop- 
mental time, these different hematopoietic cell types are 
found in the developing liver rudiment in the identical se- 
quence(reviewed by Medvinsky, 1993). Previously, migra- 
tion of hematopioetic cells from the yolk sac to the fetal 
liver has been strongly suggested (Johnson and Moore, 
1975; Cuddenec et al., 1981; Houssaint, 1981). This, in 
combination with the various hematopoietic cell types aris- 
ing in the yolk sac, AGM region, or both, is suggestive of 
waves of hematopoietic activity emerging in the fetal liver. 
As shown in Figure 7, committed precursors (CFU-C) aris- 
ing in the yolk sac could be responsible for the first wave 
of hematopoietic activity observed in the liver at the 28 
somite pair stage. Later in the second wave, CFU-S activity 
primarily from the AGM region could contribute to the ap- 
pearance of CFU-S in the liver at the 40 somite pair stage. 
Finally, HSCs from the AGM region could contribute to 
stem cell activity in the liver at 11 dpc. Precedence for 
waves of hematopoietic activity has been previously estab- 
lished in the colonization of the avian thymus (Coltey et 
al., 1987, 1989). 
CFU-C @ 
Figure 8. Model of Hematopoietic Stem Cell Maturation 
The kinetic appearance of various hematopoietic activities in the early 
developing mouse embryo is shown. Long-term repopulating (LTR) 
activity is observable in the mouse embryo only at late IO dpc, while 
CFU-C and CFU-S activity generally appear at 8 and 9 dpc, respec- 
tively. This could suggest a sequence in which a more primitive embry- 
onic cell(s) is first capable of only committed activity to differentiated 
hematopoietic cells, then acquires the ability to form progenitor cells 
for CFU-S activity, and only later matures to full competence to become 
a multilineage long-term repopulating HSC. Alternatively, this se- 
quence of appearance could be the result of low cell number or limits 
of detection of individual assays. In addition, it is unknown whether 
these functional hematopoietic activities are directly related through 
the progeny of a single cell or are independently established as indi- 
cated by the dotted lines. 
How is it then that differentiated hematopoietic cells, 
committed progenitors, and CFU-S progenitors appear in 
the mouse embryo before long-term repopulating cells? 
Unlike the adult hematopoietic system, in which the clas- 
sical hierarchical scheme illustrates stem cell to CFU-S 
progenitor to committed cell to differentiated cell produc- 
tion, these activities appear to develop in the reverse order 
in the embryo (Figure 8). Our observation that stem cell 
activity does not develop until 10 dpc raises a number of 
interesting possibilities: embryonic HSCs cannot function- 
ally repopulate adult recipients; the frequency of the long- 
term repopulating cell in the early embryo compared with 
the committed progenitors is initially low and undetectable 
because of seeding inefficiency in the transplant recipi- 
ents; embryonic HSCs are intrinsically programmed to 
produce large numbers of differentiated cells, then com- 
mitted progenitors, and finally adult repopulating HSCs in 
this sequence; specific microenvironments direct a small 
number or pool of prestem or stem cells to various activi- 
ties. In early developing yolk sac, they are directed to the 
formation of differentiated hematopoietic cells and only 
later, when other growth factors/receptors or microenvi- 
ronments (intraembryonic) become available can interme- 
diate progenitors (CFU-S) develop. Finally, definitive stem 
cell potential is acquired only after competency factors/ 
specific microenvironments (for example, expansion or 
self-renewal) become available in the embryo. 
These scenarios cannot be distinguished at the present 
time, nor can the number of initial prestem or stem cells 
be determined. We are presently establishing organ cul- 
ture and stromat coculture systems along with clonal ret- 
roviral marking of 9,10, and 11 dpc AGM region, yolk sac, 
and liver to address these questions. Also, the lineage 
relationship of the stemlprestem cells involved in produc- 
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tion of the various embryonic hematopoietic activities can- 
not be determined. Various cell surface markers, Sea-1, 
AA4.1, and Thy-l have been described for HSCs of the 
adult mouse bone marrow and fetal liver. Recent studies 
by Huang et al. (1994) have shown that unlike fetal and 
adult HSCs, yolk sac cells from late day 10 embryos ex- 
pressAA4.7 but not Sea-7. We have performed preliminary 
reverse transcriptase-PCR analysis of RNA from 10 dpc 
embryonic tissues using primers specific for the Sea-7 
gene (Ly-6AIE) and have found high expression in the 
AGM region and only very low expression in the yolk sac. 
We are presently attempting to enrich for HSCs from the 
AGM region using the Sea-1 and AA4.1 antibodies. It 
would be very interesting if AGM cells expressed both 
markers, perhaps indicating a more developmentally ad- 
vanced stem cell phenotype. This marker could be ex- 
tremely useful in determining the sequence of events (for 
example, expansion or migration) leading to the develop- 
ment of functional HSCs in the mouse embryo. 
Experimental Procedures 
Cell Preparations 
(CBA x C57BUlO)Fl females were bred with transgenic heterozy 
gous or homozygous males for the human globin gene (Strouboulis 
et al., 1992). The appearance of the vaginal plug was designated as 
day 0. Embryos were aseptically removed from uteri and dissected 
with tungsten needles in L-15 medium (Flow Lab) with 5% fetal calf 
serum under the dissection microscope. Individual embryonic tissues 
were further dispersed with the use of tungsten needles and then 
incubated for I-1.5 hr in 0.1% collagenase with 10% fetal calf serum 
at 37OC. After gentle pipetting and washing, cells were injected intrave- 
nously in the tail vein of 2- to 3-month-old irradiated (CBA x C57BU 
1O)Fl female mice. The recipients were exposed to a split dose of 
1000 rads of a BDCo source. The embryo tissue cells were coinjected 
with either 2 x 104 female bone marrow cells or with 2.5 x IO5 adult 
female splenocytes for immediate short-term radiation protection. 
These doses were limiting for long-term survival, as we found that 
about 50% of control-injected animals died within 2 months. All nonin- 
jeded irradiation control mice died within 14 days. Mice were housed 
in positive pressure cabinets and received neomycin (0.16 g/l00 ml) 
in their drinking water for the first 4 weeks following the irradiation. 
All animals were obtained from the specific pathogen-free breeding 
facility at the National Institute for Medical Research, London, and all 
animal procedures were in accordance with the Animals Scientific 
Procedures Act, 1986, United Kingdom. 
DNA Preparation, PCR, and Southern Blot Analysis 
Whole genomic DNA was isolated from the peripheral blood and tis- 
sues of recipient animals by proteinase K digestion, phenol-chloro- 
form extraction, and isopropanol precipitation as described in Maniatis 
et al. (1982). Positive displacement pipettes or filter tips were used 
and reagents and materials were specially handled for utilization in 
PCR. The PCR reaction was done as follows: 200 ng of genomic DNA 
was added to a mixture containing 1 U Taq polymerase (Biotaq), PCR 
buffer (Biotaq), PCR primers (100 ng each), and 0.2 mM nucleotides 
(Perkin-Elmer Cetus). The sequences of the PCR primers are as fol- 
lows: Sry primers, 5’-TCA TGA GAC TGC CAA CCA CAG9’and 5’-CAT 
GAC CAC CAC CAC CAC CAA-3’ (Koopman et al., 1991); myogenin 
primers, 5’-TTA CGT CCA TCG TGG ACA GC-3’ and 5’-TGG GCT 
GGG TGT TAG TCT TA-3’; and the human @globin primers 5’-CTT 
CAG GTT CCC AGT GAG GAT G-Bland 5’-GCT CCC TAA GGG GTA 
AAG AGT G-3’. The reactions for the combination Sry-myogenin PCR 
were initially heated at 94OC for 10 min, followed by 26-33 cycles of 
94OC for 10 s, 65OC for 30 s, followed 10 min at 72OC; the cycle 
parameter for the human P-globin and myogenin primers was 94’C 
for IO s, 26-33 cycles of 94“C for 10 s, 55OC for 30 s, 72OC for 1 min, 
followed by 10 min at 72OC. The cycles were done in a Techne PHC2 
thermocycler. The sizes of the amplified PCR products are 441 bp 
(Sry), 428 bp (human B-globin), and 245 bp (myogenin). The products 
were separated on 1.5% agarose gels, transferred to nylon mem- 
branes, and hybridized with an Sry-specific probe (~422, gifl of J. Gub- 
bay) and gel-purified myogenin, human kglobin fragments, or both 
after PCR amplification. A semilinear relationship was obtained be- 
tween the amount of input DNA and signal strength of the PCR product 
after quantitation by phosphorimage analysis (A. M. M. and E. D., 1993). 
For genomic Southern blots, 5 wg of genomic DNA were digested 
over night with EcoRl and separated on a 1% agarose gel. After blot- 
ting, the filters were hybridized with a 3.3 kb EcoRl probe specific for 
the human P-globin transgene (Blom van Assendelfi et al., 1989) and 
a 1.3 kb Apal Thy-7 gene fragment (Giguere et al., 1985). After expo- 
sure to X-ray film, the filter was stripped and reprobed with a Y chromo- 
some-specific probe @Y-2, Lamar and Palmer, 1984). All probes were 
radioactively labeled by nick translation (Amersham). The percentage 
engraftment was determined by quantitation of radioactive fragments 
on a phosporimager (Molecular Dynamics), densitometer (Chro- 
moscan 3) or both. 
In Vitro Cultures 
To expand and support the growth of B cells, a single cell suspension 
from spleen was cultured in 10 pg/ml lipopolysaccharide (Sigma) in 
complete medium; to obtain splenic T cells, spleen cells were grown 
in complete medium supplemented with 1 O-40 U/ml murine interleukin 
2 (IL-2) (Biosource) and 5 pglml Concanavalin A (Sigma). Complete 
medium consists of RPM1 1640, 5% FCS, 2 mM L-Glutamine, 10 mM 
HEPES, 10 U/ml penicillin, 10 wglml streptomycin. and 0.1 mM 
P-mercaptoethanol. Cells were cultured for 3-4 days at 37OC and 5% 
CO*. After cell harvest, the identity of the cells was verified by fluores- 
cence-activated cell sorter (FACS) analysis. At least 80%-90% of the 
cells grown under T cell growth conditions were Thy-1 positive. Of the 
splenocytes grown under B cell growth conditions, 800/o-90% were 
positive for 8220. Genomic DNA was prepared from the harvested 
cells and analyzed by PCR as described above. 
Macrophages were obtained from the adherent cell fraction of perito- 
neal wash, bone marrow, or spleen cells and expanded in complete 
medium with 10% L929-conditioned medium for 4-7 days. Cells were 
lysed directly on the tissue culture plate for DNA preparation. Bone 
marrow-derived mast cells were established from the nonadherent 
fraction of bone marrow cells. Cultures were maintained for a period 
of 4 weeks in RPM 1640, lOa/, FCS, nonessential amino acids, 40 
WM B-mercaptoethanol, 2 mM L-Glutamine, 10 U/ml penicillin, and lo- 
20 U of IL-3. Mast cells were identified by staining with May-GrOnwaldl 
Giemsa dye. 
RNA Analysis 
Approximately 100 pl of peripheral blood was obtained from transplant 
recipients by tail vein nicking. Blood RNA was extracted with RNAzol 
B (Cinna/Biotecx) and expression analysis of globin genes was carried 
out as described in Strouboulis et al. (1992); all Sl probes are as 
previously described (Kollias et al., 1986; Fraser et al., 1990; Lin- 
denbaum and Grosveld, 1990). Quantitation was performed by densi- 
tometry using the mouse b major signal as an RNA normalization 
control and human P-globin signal in Figure 8, lane 7 as the 100% 
expression control. 
Acknowledgments 
The authors would like to thank C. Miles, B. Daly, Dr. J. Ellis, and 
S. Jenkins for assistance in various aspects of this work. We also 
acknowledge the productive discussions with other members of the 
lab and with Dr. I. Lemischka. We thank Drs. R. Mulligan, P. Rigby, 
and V. Tybulewicz for critical reviews of the manuscript. This work 
was supported by an European Molecular Biology Organization Fel- 
lowship to A. M. M., a Royal Society Fellowship to A. M., the Howard 
Hughes Medical Institute, and the Medical Research Council, United 
Kingdom. 
Received April 27, 1994; revised May 13, 1994. 
Immunity 
300 
References 
Blom van Assendelft, G., Hanscombe, O., Grosveld, F., and Greaves, 
D. R. (1969). The 8-globin dominant control region activates homolo- 
gous and heterologous promoters in a tissue-specific manner. Ceil 
58,989-977. 
Coltey, M., Jotereau, F. V., and Le Douarin, N. M. (1987). Evidence 
for a cyclic renewal of lymphocyte precursor cells in the embryonic 
chick thymus. Cell Differ. 22, 71-62. 
Coltey, M., Bucy, Ft. P., Chen, C. H., Cihak, J., Losch, U., Char, D., 
Le Douarin, N. M., and Cooper, M. D. (1969). Analysis of the first 
two waves of thymus homing stem cells and their T cell progeny in 
chick-quail chimeras. J. Exp. Med. 770, 543-557. 
Cormier, F., and Dieterlen-Lievre, F. (1988). The wall of the chick em- 
bryo aorta harbours M-CFC, G-CFC, GM-CFC and BFU-E. Develop 
ment 702, 279-285. 
Cuddenec, C. A., Thiery, J.-P., and Le Douarin, N. M. (1981). In vitro 
induction of adult erythropoiesis in early mouse yolk sac. Proc. Natl. 
Acad. Sci. USA 78,2412-2415. 
Cumano, A., Furlonger, C., and Paige, C. J. (1993). Differentiation 
and characterization of B-cell precursors detected in the yolk sac and 
embryo body of embryos beginning at the 1 O-to 1 P-somite stage. Proc. 
Natl. Acad. Sci. USA 90, 6429-8433. 
Dieterlen-Lievre, F. (1975). On the origin of haematopoietic stem cells 
in the avian embryo: an experimental approach. J. Embryol. Exp. Mor- 
phol. 33, 607-819. 
Dieterlen-Lievre, F., and Martin, C. (1981). Diffuse intraembryonic he- 
mopoiesis in normal and chimeric avian development. Dev. Biol. 88, 
180-191. 
Dolci, S., Williams, D. E., Ernst, M. K., Resnick, J. L., Brannan, C. I., 
Lock, L. R., Lyman, S. D., Boswell, H. S., and Donovan, P. J. (1991). 
Requirement for mast cell growth factor for primordial germ cell sur- 
vival in culture. Nature 352, 809-811. 
Fraser, P., Hurst, J., Collis, P., and Grosveld, F. (1990). DNAasel 
hypersensitive sites 1,2 and 3 of the human 6.globin dominant control 
region direct position-independent expression. Nucl. Acids Res. 18, 
3503-3508. 
Giguere, V., Isobe, K.-l., and Grosveld, F. (1985). Structure of the 
murine Thy-7 gene. EMBO J. 4, 2017-2024. 
Godin, I., Deed, Ft., Cooke, J., Zsebo, K., Dexter, M., and Wylie, C. C. 
(1991). Effects of the steel gene product on mouse primordial germ 
cells in culture. Nature 352, 807-809. 
Godin, I. E., Garcia-Porrero, J. A., Coutinho, A., Dieterlen-Lievre, F., 
and Marcos, M. A. R. (1993). Para-aortic splanchnopleura from early 
mouse embryos contains Bla cell progenitors. Nature 384, 67-70. 
Harrison, D. E. (1980). Competitive repopulation: a new assay for long- 
term stem cell functional capacity. Blood 55, 77-81. 
Harrison, D. E., Astle, C. M., and DeLaitre, J. A. (1979). Processing 
by the thymus is not required for cells that cure and populate WiVr 
recipients. Blood 54, 1152-1157. 
Houssaint, E. (1981). Differentiation of the mouse hepatic primordium. 
II. Extrinsic origin of the hematopoietic cell line. Cell Diff. 70, 243- 
252. 
Huang, H., and Auerbach, R. (1993). Identification and characteriza- 
tion of hematopoietic stem cells from the yolk sac of the early mouse 
embryo. Proc. Natl. Acad. Sci. USA 90, 101 lo-101 14. 
Huang, H., Zettergren, L. D., and Auerbach, R. (1994). In vitro differen- 
tiation of B cells and myeloid cells from the early mouse embryo and 
its extraembryonic yolk sac. Exp. Hematol. 22, 19-25. 
Johnson, G. R., and Jones, R. 0. (1973). Differentiation ofthe mamma- 
lian hepatic primordium in vitro. I. Morphogenesis and the onset of 
hematopoiesis. J. Embryol. Exp. Morphol. 30, 83-96. 
Johnson, G. R., and Moore, M. A. S. (1975). Role of stem cell migration 
in initiation of mouse foetal liver haemopoiesis. Nature 258, 728-728. 
Johnson, G. Ft., and Barker, D. C. (1985). Erythroid progenitor cells 
and stimulating factors during murine embryonic and fetal develop. 
ment. Exp. Hematol. 73, 200-208. 
Jordan, C. T., and Lemischka, I. Ft. (1990). Clonal and systemic anaiy 
sis of long term hematopoiesis in the mouse. Genes Dev. 4, 220-232. 
Jordan, 6. T., McKearn, J. P., and Lemischka, I. R. (1990). Cellular 
and developmental properties of fetal hematopoietic stem cells. Cell 
87, 953-983. 
Keshet, E., Lyman, S. D., Williams, D. E., Anderson, D. M., Jenkins, 
N. A., Copeland, N. G., and Parada, L. F. (1991). Embryonic RNA 
expression patterns of the c-kit receptor and its cognate ligand suggest 
multiple functional roles in mouse development. EMBO J. 70, 2425- 
2435. 
Kollias, G., Wrighton, N., Hurst, J., and Grosveld, F. (1988). Regulated 
expression of human y-, 8- and hybrid y8-globin genes in transgenic 
mice: manipulation of the developmental expression patterns. Cell 48, 
89-94. 
Koopman, P., Gubbay, J., Vivian, N., Goodfellow, P., and Lovell- 
Badge, R. (1991). Male development of chromosomally female mice 
transgenic for Sry. Nature 357, 117-121. 
Lamar, E. E., and Palmer, E. (1984). Y-encoded species-specific DNA 
in mice: evidence that the Y chromosome exists in two polymorphic 
forms in inbred strains. Cell 37, 171-177. 
Lindenbaum, M. H., and Grosveld, F. (1990). An in vitro globin gene 
switching model based on differentiated embryonic stem cells. Genes 
Dev. 4, 2075-2085. 
Liu, C.-P., and Auerbach, R. (1991). In vitro development of murine 
T cells from prethymic and preliver embryonic yolk sac hematopoietic 
stem cells. Development 773, 1315-1323. 
Maeno, M., Tochinai, S., and Katagiri, C. (1985). Differential participa- 
tion ofventral and dorsolateral mesoderms in the hemopoiesis of Xeno- 
pus, as revealed in diploid-triploid or interspecific chimeras. Dev. Biol. 
7 70, 503-508. 
Maniatis, T., Fritsch, V., and Sambrook, J. (1982). Molecular Cloning: 
A Laboratory Manual (Cold Spring Harbor, New York: Cold Spring 
Habor Laboratory Press). 
Matsui,Y.,Zsebo, K. M., and Hogan B. L. M(1990). Embryonicexpres- 
sion of a haematopoietlc growth factor encoded by the SL locus and 
the ligand for c-kit. Nature 347, 887-669. 
Medvinsky, A. L. (1993). Ontogeny of the mouse hematopoietic sys- 
tem. Sem. Dev. Biol. 4, 333-340. 
Medvinsky, A. L., Samoylina, N. L., Miiller, A. M., and Dzierzak, E. A. 
(1993). An early pre-liver intra-embryonic source of CFU-S in the devel- 
oping mouse. Nature 364, 64-67. 
Micklem, H. S., Ford, C. E., Evans, E. P., and Gray, J. (1986). Interrela- 
tionships of myeloid and lymphoid cells studies with chromosome- 
marked cells transplanted into lethally irradiated mice. Proc. R. Sec. 
785, 78. 
Moore, M. A. S., and Metcalf, D. (1970). Ontogeny of the haematopoie- 
tic system: yolk sac origin of in vivo and in vitro colony forming cells 
in the developing mouse embryo. Br. J. Haematol. 78, 279-296. 
Mtiller, A. M., and Dzierzak, E. A. (1993). ES cells have only a limited 
lymphopoietic potential after adoptive transfer into mouse recipients, 
Development 778, 1343-1351. 
Palacios, ft., and Imhof, B. A. (1993). At day 8-8.5 of mouse develop. 
ment the yolk sac, not the embryo proper, has lymphoid precursor 
potential in vivo and in vitro. Proc. Natl. Acad. Sci. USA 90, 8581- 
6585. 
Perah, G., and Feldman, M. (1977). In vitro activation of the in vivo 
colony-forming units of the mouse yolk sac. J. Cell. Physiol. 97, 193- 
199. 
Cgawa, M., Nishikawa, S., Ikuta, K., Yamamura, F., Naito, M., Taka- 
hashi, K., and Nishikawa, S-I. (1988). B cell ontogeny in murine em- 
bryo studied by a culture system with the monolayer of a stromal cell 
clone, ST2: B cell progenitor develops first in the embryonal body 
rather than in the yolk sac. EMBO J. 7, 1337-1343. 
Russell, E. S. (1979). Hereditary anemias of the mouse: a review for 
geneticists. Adv. Genet. 20, 357-459. 
Russell, E. S., and Bernstein, S. E. (1988). Blood and blood formation. 
In Biology of the Laboratory Mouse, Second Edition, E. L. Green, ed. 
(New York: McGraw-Hill), pp. 351-372. 
Samoylina, N. L., Gan, 0. I., and Medvinsky, A. L. (1990). Development 
of the hemopoietic system: splenic colony forming units in mouse em- 
bryogenesis. Sov. J. Dev. Biol. 27, 127-133. 
Embryonic Hematopoietic Stem Cells 
301 
Samoylina, N. L., Medvinsky, A. L., Gan, 0. I., and Manakova, T. E. 
(1992). Hemopoietic stem cells in embryogenesis of the mouse, In 
Hematology and Blood Transfusion, Volume 35, Modern Trends in 
Human Leukemia, R. Neth, E. Frolova, R. C. Gallo, M. F. Greaves, 
B. V. Afanasev, and E. Elstener, eds. (Berlin: Springer), pp. 106-109. 
Sonoda, T., Hayashi, C., and Kitamura, Y. (1963). Presence of mast 
cell precursors in the yolk sac of mice. Dev. Biol. 97, 89-94. 
Spangrude, G. J., Heimfeld, S., and Weissman, I. L. (1988). Purifica- 
tion and characterization of mouse hematopoietic stem cells. Science 
241, 56-62. 
Strouboulis, J., Dillon, N., and Grosveld, F. (1992). Developmental 
regulation of a complete 70-kb human 8-globin locus in transgenic 
mice. Genes Dev. 6, 1857-l 864. 
Symann, M., Anckaert, M. A., Cordier, A., Rodhain, J., and Sokal, 
G. (1978). Murine yolk sac hematopoiesis studied with the diffusion 
chamber technique. Exp Hematol. 6, 749-759. 
Tavassoli, M. (1994). Embryonic origin of hematopoietic stem cells. 
Exp. Hemat. 22, 7. 
Tales, J. F., Chui, D. H. K., Belbeck, L. W., Starr, E., and Barker, 
J.E. (1989). Hemopoietic stem cells in murine embryonic yolk sac and 
peripheral blood. Proc. Natl. Acad. Sci. USA 86, 7456-7459. 
Turpen, J. B., Knudson, C. M., and Hoefen, P. S. (1961). The early 
ontogeny of hematopoietic cells studied by grafting cflogenetically 
labeled tissue anlagen: localization of a prospective stem cell compart- 
ment. Dev. Biol. 85, 99-l 12. 
Weissman, I. L., Baird, S., Gardner, R. L., Papaioannou, V. E., and 
Raschke, W. (1977). Normal and neoplastic maturation of T-lineage 
lymphocytes. Cold Spring Harbor Symp. Quant. Biol. 47, 9-21, 
Weissman, I., Papaioannou, V., and Gardner, R. (1978). Fetal hemato- 
poietic origins of the adult hematolymphoid system. In Differentiation 
of Normal and Neoplastic Hematopoietic Cells (Cold Spring Harbor, 
New York: Cold Spring Harbor Laboratory Press), pp. 33-47. 
Witte, 0. N. (1990). Steel locus defines new multipotent growth factor. 
Cell 63, 5-6. 
Wong, P. M. C., Chung, S. W., Chui, D. H. K., and Eaves, C. J. (1986). 
Properties of the earliest clonogenic hemopoietic precursors to appear 
in the developing murine yolk sac. Proc. Natl. Acad. Sci. USA 83, 
3851-3854. 
